Latest Endo Health Solutions Inc. Stories

-- Restructuring Expected To Reduce Annual Operating Expenses By $325 Million MALVERN, Pa., June 5, 2013 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today outlined the strategic, operational and organizational steps it is taking to refocus the Company and drive shareholder value. These actions are the result of a comprehensive assessment of Endo's strengths and challenges, its cost structure and execution capabilities, and its most promising opportunities to drive...

MALVERN, Pa., May 30, 2013 /PRNewswire/ -- Endo Pharmaceuticals Inc., a subsidiary of Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has issued a complete response letter regarding the New Drug Application (NDA) for Endo's long-acting testosterone undecanoate injection, AVEED(TM), for men diagnosed with hypogonadism. The complete response letter did not include requests for the company to perform additional clinical...

MALVERN, Pa., May 29, 2013 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Alan G. Levin, Executive Vice President & Chief Financial Officer, will be leaving the Company. Mr. Levin will continue in his current role until the fall, while a search is conducted for his successor. The Board of Directors has formed a search committee and engaged a leading search firm to assist in an external search for a new CFO. Rajiv De Silva, Chief Executive...

MALVERN, Pa., May 29, 2013 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) today announced that Julie H. McHugh, Chief Operating Officer, is leaving the Company, effective immediately. Rajiv De Silva, Chief Executive Officer, said, "The Board and I want to thank Julie for her dedicated service and significant contributions to building Endo into one of the leading public diversified healthcare companies." About Endo Endo Health Solutions Inc. (Endo) is a U.S.-based...

HONG KONG, May 14, 2013 /PRNewswire/ -- Insiderslab.com has issued insider trading reports for stock investing: J.C. Penney (NYSE:JCP), Gilead Sciences (NASDAQ:GILD), Chesapeake Energy (NYSE:CHK), Annaly Capital Management (NYSE:NLY), Endo Health Solutions (NASDAQ:ENDP), and Zynga (NASDAQ:ZNGA). (Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO ) (Read full report by clicking the link below, you may need to copy and paste the full link to your browser.) Report...

MALVERN, Pa., May 10, 2013 /PRNewswire/ -- Endo Health Solutions Inc. (Nasdaq: ENDP) announced today that the U.S. Food and Drug Administration (FDA) has denied a Citizen Petition filed by its subsidiary, Endo Pharmaceuticals Inc. Endo presented FDA data collected from an ongoing epidemiology study that indicate that per 100,000 prescriptions dispensed, the past 30-day abuse rate of crush-resistant OPANA ER was 79 percent lower than the abuse rate of generic versions of...

MALVERN, Pa., May 7, 2013 /PRNewswire/ -- Total quarterly revenues of $709 million, increased by 3 percent versus prior year. First quarter reported diluted (GAAP) EPS of $0.14. First quarter adjusted diluted EPS of $1.09 increased by 25 percent versus prior year. Company continues to expect 2013 revenues in the range of $2.80 billion to $2.95 billion. Company now expects reported diluted (GAAP) EPS in the range of $2.10 to $2.40. Company continues to expect 2013 adjusted...

MALVERN, Pa., April 15, 2013 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) will announce its first quarter 2013 financial results before the open of the U.S. financial markets on May 7, 2013 and members of its senior management team will host a conference call and webcast at 8:30 a.m. ET that day to discuss these results. Investors and other interested parties may call 800-510-9691 (domestic) or 617-614-3453 (international) and enter passcode 52909269. Please dial in 10...

MALVERN, Pa., March 5, 2013 /PRNewswire/ -- Endo Health Solutions (Nasdaq: ENDP) today announced that Alan Levin, chief financial officer, will present a corporate overview at the Cowen and Company 33rd Annual Health Care Conference on Wednesday, Mar. 6, 2013, at 10:00 a.m. Eastern Time. A live webcast and audio archive of the presentation will be available on the company's website at www.endo.com. Click on Investor Relations, and then the link to the Event and Presentation....

MALVERN, Pa., Feb. 28, 2013 /PRNewswire/ -- Total quarterly revenues of $801 million, comparable to prior year. Fourth quarter reported diluted (GAAP) loss per share of $6.35 includes a $640 million non-cash asset impairment charge related primarily to goodwill and other intangible assets attributable to the company's American Medical Systems (AMS) segment. Fourth quarter adjusted diluted EPS of $1.62 increased by 16 percent versus prior year; Full year 2012 adjusted diluted EPS...